HEPATIC TM6SF2 SUPRRESSES NAFLD-HCC THROUGH ACTIVATING ANTITUMOR IMMUNITY

被引：0
|
作者：
Zhang, Yating
Xie, Mingxu
Liu, Weixin
Liang, Cong
Wen, Jun
Yu, Jun
Zhang, Xiang
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Tu1559
引用
收藏
页码：S1414 / S1414
页数：1
相关论文
共 50 条
  • [41] TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
    Luo, Fei
    Oldoni, Federico
    Das, Avash
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (03) : 448 - 460
  • [42] THE OVEREXPRESSION OF TM6SF2 AND/OR MBOAT7 WILD-TYPE GENES RESTORES THE MITOCHONDRIAL LIFECYCLE AND ACTIVITY IN AN IN VITRO NAFLD MODEL
    Paolini, Erika
    Longo, Miriam
    Meroni, Marica
    Tria, Giada
    Piciotti, Roberto
    Ruscica, Massimiliano
    Fracanzani, Anna Ludovica
    Dongiovanni, Paola
    HEPATOLOGY, 2023, 78 : S1139 - S1140
  • [43] COMPARISON OF HEPATIC STELLATE CELLS ACTIVATION BY TM6SF2 rs58542926 POLYMORPHISM USING IN VITRO OVEREXPRESSION MODEL
    Liu, Songyao
    Murakami, Eisuke
    Chayama, Kazuaki
    HEPATOLOGY, 2019, 70 : 1318A - 1319A
  • [44] TM6SF2 and MBOAT7 Gene Variants in Liver Fibrosis and Cirrhosis
    Basyte-Bacevice, Viktorija
    Skieceviciene, Jurgita
    Valantiene, Irena
    Sumskiene, Jolanta
    Petrenkiene, Vitalija
    Kondrackiene, Jurate
    Petrauskas, Dalius
    Lammert, Frank
    Kupcinskas, Juozas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (06)
  • [45] TM6SF2 Promotes Lipidation and Secretion of Hepatitis C Virus in Infected Hepatocytes
    Boyer, Audrey
    Park, Seung Bum
    de Boer, Ynto S.
    Li, Qisheng
    Liang, T. Jake
    GASTROENTEROLOGY, 2018, 155 (06) : 1923 - +
  • [46] TM6SF2 E167K Variant Overexpression Promotes Expression of Inflammatory Cytokines in the HCC Cell Line HEPA 1-6
    Du, Shuixian
    Liao, Songling
    Liu, Shousheng
    Xin, Yongning
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2019, 7 (01) : 27 - 31
  • [47] INTESTINAL TM6SF2 PROTECTS AGAINST NON-ALCOHOLIC STEATOHEPATITIS THROUGH GUT-LIVER AXIS
    Zhang, Xiang
    Liang, Cong
    Lau, Harry C.
    Ha, Suki
    Wong, Chi Chun
    Yu, Jun
    GASTROENTEROLOGY, 2023, 164 (06) : S1251 - S1251
  • [48] No association of NAFLD-related polymorphisms in PNPLA3 and TM6SF2 with all-cause and cardiovascular mortality in an Austrian population study
    Georg Semmler
    Lorenz Balcar
    Sarah Wernly
    Leonora Datz
    Marie Semmler
    Lea Rosenstatter
    Felix Stickel
    Elmar Aigner
    Bernhard Wernly
    Christian Datz
    Wiener klinische Wochenschrift, 2024, 136 : 251 - 257
  • [49] THE OVEREXPRESSION OF TM6SF2 AND/OR MBOAT7 WILD-TYPE GENES RE-ESTABLISHES THE MITOCHONDRIAL DYNAMICS IN AN IN VITRO NAFLD MODEL
    Paolini, Erika
    Longo, Miriam
    Meroni, Marica
    Paolini, Erika
    Macchi, Chiara
    Piciotti, Roberto
    Agresta, Adele
    Ruscica, Massimiliano
    Fracanzani, Anna Ludovica
    Dongiovanni, Paola
    HEPATOLOGY, 2022, 76 : S798 - S799
  • [50] Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development
    Chouik, Yasmina
    Di Filippo, Mathilde
    Radenne, Sylvie
    Dumortier, Jerome
    Moulin, Philippe
    Levrero, Massimo
    LIVER INTERNATIONAL, 2024, 44 (06) : 1474 - 1477
12345